Oncotarget: CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy
CABYR expression in tumors was further confirmed by immunohistochemistryCredit: Correspondence to - Richard L. Whelan - Rwhelan1@northwell.edu Oncotarget published "The ...